Management of Proteinuria and UTI
Initial Assessment and Diagnosis
- The presence of leukocytes and nitrites in urinalysis strongly indicates an active urinary tract infection that requires immediate treatment 1
- Obtain urine culture before starting antibiotics to identify the causative pathogen and its susceptibility pattern 1
- Start empiric antimicrobial therapy based on local resistance patterns while awaiting culture results 1
- ACR of 60.4 mg/mmol indicates significant proteinuria (>0.5 g/day), which requires further evaluation and treatment 2
- Significant proteinuria (ACR >60 mg/mmol) with hematuria suggests possible glomerular disease that may require nephrology referral 3
- Assess for risk of progression by evaluating proteinuria level, blood pressure, and eGFR 4
Treatment Algorithm
- For uncomplicated lower UTI, use first-line options including fosfomycin, nitrofurantoin, or pivmecillinam 1
- For suspected pyelonephritis (if patient has fever, flank pain), use oral fluoroquinolones or cephalosporins 1
- Adjust antibiotic dosing based on renal function 1
- Repeat urinalysis after completion of treatment to confirm resolution 1
- After resolving the acute infection, initiate ACE inhibitor or ARB treatment for persistent proteinuria >0.5 g/day 2, 4
- Titrate the ACE inhibitor or ARB upward as tolerated to achieve proteinuria <1 g/day 2, 4
- Target blood pressure <125/75 mmHg when proteinuria is >1 g/day 4
Follow-up and Monitoring
- Reassess urinalysis after completion of antibiotic treatment to confirm resolution of UTI 1
- Monitor renal function and electrolytes within 1-2 weeks of starting ACE inhibitor or ARB therapy 2
- Check for hyperkalemia, which is a common side effect of ACE inhibitors and ARBs 2
- Regular monitoring of proteinuria, blood pressure, and eGFR to assess response to treatment and risk of progression 2, 4
- If proteinuria persists despite optimal treatment, consider nephrology referral for possible renal biopsy 3
Important Considerations and Pitfalls
- Do not attribute proteinuria solely to UTI if it persists after treatment of infection 3
- Counsel patients to temporarily hold ACE inhibitors or ARBs during periods of volume depletion or acute illness 2
- Avoid treating asymptomatic bacteriuria except in specific populations such as pregnancy or before urologic procedures 1